Published on 9/19/2003 in the Prospect News Convertibles Daily.
New Issue: Merrill prices $44 million 0% notes linked to Pfizer
New York, Sept. 19 - Merrill Lynch & Co., Inc. priced $44 million 0% accelerated return notes linked to Pfizer Inc., according to a filing with the Securities and Exchange Commission.
| Issuer: | Merrill Lynch & Co., Inc.
|
| Issue: | Accelerated return senior notes
|
| Underlying stock: | Pfizer Inc.
|
| Amount: | $44 million
|
| Maturity: | Nov. 23, 2004
|
| Coupon: | 0%
|
| Price: | Par of $25
|
| Payout at maturity: | Par plus triple percentage increase in Pfizer stock up to a total of $29.31 per note or par less percentage decrease
|
| Call: | Non-callable
|
| Pricing date: | Sept. 17
|
| Settlement: | Sept. 23
|
| Underwriter: | Merrill Lynch & Co.
|
| Listing: | "APP" on America Stock Exchange
|
| Distribution: | Off shelf
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
